3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
21
Lung Neoplasms
18
Glioma
13
Neoplasm Metastasis
12
Urinary Bladder Neoplasms
11
Carcinoma, Non-Small-Cell Lung
11
Breast Neoplasms
11
Pancreatic Neoplasms
10
Multiple Myeloma
10
Lymphoma
10
Squamous Cell Carcinoma of Head and Neck
9
Mouth Neoplasms
9
Melanoma
8
Colorectal Neoplasms
8
Carcinoma, Renal Cell
8
Ovarian Neoplasms
7
Oropharyngeal Neoplasms
7
Laryngeal Neoplasms
7
Glioblastoma
7
Carcinoma, Hepatocellular
7
Carcinoma
7
Wilms Tumor
6
Sarcoma
6
Neuroblastoma
6
Nasopharyngeal Carcinoma
6
Medulloblastoma
6
Lymphoma, Non-Hodgkin
6
Fallopian Tube Neoplasms
6
Triple Negative Breast Neoplasms
5
Thyroid Neoplasms
5
Interventions
Cyclophosphamide
10
fludarabine
7
pomalidomide
5
pembrolizumab
5
Dexamethasone
5
daratumumab
4
obinutuzumab
3
glofitamab
3
fludarabine phosphate
3
abemaciclib
3
Rituximab
3
Melphalan
3
Immunotherapy, Adoptive
3
Etoposide
3
Bortezomib
3
zanubrutinib
2
venetoclax
2
tocilizumab
2
pirtobrutinib
2
palbociclib
2
cemiplimab
2
blinatumomab
2
Temozolomide
2
Sirolimus
2
Oxaliplatin
2
Nivolumab
2
Mesna
2
Letrozole
2
Injections
2
Gemcitabine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
Magnetic Resonance Spectroscopy
×
30 days
×
Clear all
No trials found.